CLARIVATE LIFE SCIENCES & HEALTHCARE acquired by ALTARIS

Life Sciences & Healthcare (LS&H) operates as an independent data intelligence business delivering AI‑enabled solutions to the pharmaceutical, biotechnology and medical technology sectors. The portfolio comprises the Cortellis platform, which aggregates regulatory filings, clinical‑trial data, safety information and pipeline analytics to support research and development decision‑making, and the Decision Resources Group suite, which provides epidemiology, market‑forecasting and payer‑insight tools for commercialization and market‑access planning. LS&H serves roughly 2,500 organizations worldwide, including the top twenty global pharmaceutical manufacturers, as well as mid‑size biotech firms and device innovators that require integrated insight across the drug and device lifecycle. Revenue is generated through subscription licences, data‑as‑a‑service contracts and professional services that combine analytics consulting with platform integration. The company maintains data centres in North America, Europe and Asia Pacific to ensure low‑latency access for multinational clients and complies with regional data‑privacy regulations such as GDPR and HIPAA.